Physician profile
Gregory Mark Brown
NPI 1386647956
$705.45
in general payments reported to CMS, 2019-2025
14 companies · $84.98 in 2025
The $84.98 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.47 · 2020: $105 · 2021: $24.32 · 2022: $83.42 · 2023: $33.28 · 2024: $326 · 2025: $84.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $444.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $444.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $153.50 | 2024 | Sapien 3 Ultra Resilia |
| Intuitive Surgical, INC. | $132.46 | 2024 | |
| Janssen Pharmaceuticals, INC | $110.51 | 2019-2021 | |
| Pfizer INC. | $63.29 | 2022-2025 | |
| Lilly USA, LLC | $50.90 | 2022-2025 | Mounjaro, Zepbound |
| Novartis Pharmaceuticals Corporation | $36.33 | 2020-2023 | |
| Glaxosmithkline, LLC. | $34.04 | 2022-2024 | Shingrix |
| Exact Sciences Corporation | $28.36 | 2025 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $20.14 | 2019 | |
| Merck Sharp & Dohme LLC | $17.56 | 2025 | Capvaxive |
| Astrazeneca Pharmaceuticals Lp | $16.86 | 2022 | |
| Amgen INC. | $15.97 | 2019 | |
| Boston Scientific Corporation | $13.79 | 2022 | |
| Smith+Nephew, INC. | $11.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.